Vivos (RDGL) Other financing activities (2011 - 2025)

Vivos' (RDGL) quarterly Other financing activities came in at $1500.0 in Q1 2025, down 85.0% quarter-over-quarter from $10000.0 in Q2 2018.

Analysis

Vivos (RDGL) Other financing activities (2011 - 2025) Analysis & Trends

Vivos has disclosed Other financing activities across 8 years of filings, most recently posting $1500.0 for Q1 2025.

In Q1 2025, Other financing activities changed N/A year-over-year to $1500.0; the TTM figure through Dec 2025 stood at $1500.0 (changed N/A YoY), while the FY2025 annual figure was $1500.0, down 92.25% from the prior year.
Other financing activities came in at $1500.0 for Q1 2025 at Vivos, down from $10000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $1500.0 in Q1 2025 to a low of $1500.0 in Q1 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn
10	Vivos	23.21 Mn	23.21 Mn	-

Historic Data

Download Data